Meda AB
Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.
Meda was listed on the Stockholm stock market until it was acquired by Mylan in 2016 through a cash and stock offer.In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio. Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.
